Vivani Medical revenue VANI

Sales by quarter and over the last twelve months, from 2014.

Vivani Medical's twelve-month revenue can't be added up yet: a quarter of its results is missing from our data.

In its latest quarter, Q2 FY21, it was $0.

Revenue over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	Revenue	On a year earlier	Last 12 months
Q2 FY21	Jun 30, 2021	$0	n/a	n/a
Q2 FY20	Jun 30, 2020	$0	−100%	n/a
Q4 FY19	Dec 31, 2019	$497K	−72%	$3.4M
Q3 FY19	Sep 30, 2019	$472K	−79%	$4.6M
Q2 FY19	Jun 30, 2019	$1.3M	−33%	$6.4M
Q1 FY19	Mar 31, 2019	$1.1M	+16%	$7M
Q4 FY18	Dec 31, 2018	$1.8M	−43%	$6.9M
Q3 FY18	Sep 30, 2018	$2.2M	+40%	$8.2M
Q2 FY18	Jun 30, 2018	$1.9M	−15%	$7.6M
Q1 FY18	Mar 31, 2018	$976K	−3%	$7.9M
Q4 FY17	Dec 31, 2017	$3.1M	+335%	$8M
Q3 FY17	Sep 30, 2017	$1.6M	+36%	$5.6M

Companies in Healthcare nearest Vivani Medical's size, closest first, today.

Company	Revenue, 12 months	Growth
VANIVivani Medical	n/m
KEQUKewaunee Scientific	$277.2M	+5% a year
ICCCImmucell	$30.7M	+8% a year
LFVNLifevantage	$182.6M	−20% a year
SPROSpero Therapeutics	$47M	−3% a year
APTAlpha Pro Tech	$61.9M	+6% a year
PDEXPro DEX	$77.5M	+16% a year
PLXProtalix BioTherapeutics	$80.6M	+30% a year
ATNMActinium Pharmaceuticals	n/m
NATRNatures Sunshine Products	$492M	+7% a year
ELMDElectromed	$73.8M	+15% a year
Peer median	$77.5M